Contraindicated. Coadministration of doravirine with a powerful CYP3A inducer may perhaps decrease doravirine plasma concentrations and/or effects. Potential for loss of virologic response and possible resistance to doravirine.Watch Carefully (one)pentobarbital will minimize the level or impact of tofacitinib by influencing hepatic/intestinal enzym